Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Farmers Insurance
Teva
Daiichi Sankyo
Baxter
Merck
Fish and Richardson
Moodys
McKinsey
Citi

Generated: January 21, 2018

DrugPatentWatch Database Preview

Ciprofloxacin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for ciprofloxacin hydrochloride and what is the scope of ciprofloxacin hydrochloride patent protection?

Ciprofloxacin hydrochloride
is the generic ingredient in seven branded drugs marketed by Novartis Pharms Corp, Akorn Inc, Amring Pharms, Apotex Inc, Fdc Ltd, Rising Pharms Inc, Teligent, Watson Labs Inc, Wraser Pharms, Depomed Inc, Bayer Hlthcare, Apotex, Aurobindo Pharma, Barr, Carlsbad, Dr Reddys Labs Ltd, Hikma, Idt Australia Ltd, Ivax Sub Teva Pharms, Mylan, Nostrum Labs, Pliva, Sandoz, Sun Pharm Inds Ltd, Taro Pharm, Teva, Unique Pharm Labs, Watson Labs, and Laboratorios Salvat, and is included in thirty-two NDAs. There are five patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Ciprofloxacin hydrochloride has forty-seven patent family members in seventeen countries.

There are thirty-one drug master file entries for ciprofloxacin hydrochloride. Seventy-four suppliers are listed for this compound. There are two tentative approvals for this compound.
Summary for ciprofloxacin hydrochloride
Pharmacology for ciprofloxacin hydrochloride
Ingredient-typeQuinolones
Drug ClassQuinolone Antimicrobial
Tentative approvals for CIPROFLOXACIN HYDROCHLORIDE
Applicant Application No. Strength Dosage Form
➤ Subscribe➤ SubscribeEQ 250MG BASETABLET;ORAL
➤ Subscribe➤ SubscribeEQ 750MG BASETABLET;ORAL
➤ Subscribe➤ SubscribeEQ 500MG BASETABLET;ORAL

US Patents and Regulatory Information for ciprofloxacin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 076896-001 Nov 4, 2004 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Carlsbad CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 076126-002 Jun 9, 2004 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Depomed Inc PROQUIN XR ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021744-001 May 19, 2005 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Aurobindo Pharma CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 077859-001 Apr 26, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Nostrum Labs CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 076138-003 Jun 9, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pliva CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 076426-002 Jun 15, 2005 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Unique Pharm Labs CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 076639-001 Sep 10, 2004 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs Inc CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride SOLUTION/DROPS;OPHTHALMIC 076673-001 Jan 21, 2005 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Carlsbad CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 076126-003 Jun 9, 2004 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Taro Pharm CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 076912-004 Oct 6, 2004 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ciprofloxacin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Depomed Inc PROQUIN XR ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021744-001 May 19, 2005 ➤ Subscribe ➤ Subscribe
Bayer Hlthcare CIPRO ciprofloxacin hydrochloride TABLET;ORAL 019537-003 Oct 22, 1987 ➤ Subscribe ➤ Subscribe
Novartis Pharms Corp CILOXAN ciprofloxacin hydrochloride OINTMENT;OPHTHALMIC 020369-001 Mar 30, 1998 ➤ Subscribe ➤ Subscribe
Bayer Hlthcare CIPRO ciprofloxacin hydrochloride TABLET;ORAL 019537-004 Oct 22, 1987 ➤ Subscribe ➤ Subscribe
Bayer Hlthcare CIPRO ciprofloxacin hydrochloride TABLET;ORAL 019537-003 Oct 22, 1987 ➤ Subscribe ➤ Subscribe
Bayer Hlthcare CIPRO ciprofloxacin hydrochloride TABLET;ORAL 019537-001 Apr 8, 1996 ➤ Subscribe ➤ Subscribe
Bayer Hlthcare CIPRO ciprofloxacin hydrochloride TABLET;ORAL 019537-001 Apr 8, 1996 ➤ Subscribe ➤ Subscribe
Novartis Pharms Corp CILOXAN ciprofloxacin hydrochloride SOLUTION/DROPS;OPHTHALMIC 019992-001 Dec 31, 1990 ➤ Subscribe ➤ Subscribe
Depomed Inc PROQUIN XR ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021744-001 May 19, 2005 ➤ Subscribe ➤ Subscribe
Bayer Hlthcare CIPRO ciprofloxacin hydrochloride TABLET;ORAL 019537-002 Oct 22, 1987 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for ciprofloxacin hydrochloride

Supplementary Protection Certificates for ciprofloxacin hydrochloride

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0012 France ➤ Subscribe PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
C/GB12/058 United Kingdom ➤ Subscribe PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Cantor Fitzgerald
McKinsey
Julphar
Healthtrust
Teva
Express Scripts
US Army
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot